156 related articles for article (PubMed ID: 33401948)
1. The insulin-degrading enzyme as a link between insulin and neuropeptides metabolism.
Wacławczyk D; Silberring J; Grasso G
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):183-187. PubMed ID: 33401948
[TBL] [Abstract][Full Text] [Related]
2. IDE Degrades Nociceptin/Orphanin FQ through an Insulin Regulated Mechanism.
Zingale GA; Bellia F; Ahmed IMM; Mielczarek P; Silberring J; Grasso G
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509943
[TBL] [Abstract][Full Text] [Related]
3. Formation of insulin fragments by insulin-degrading enzyme: the role of zinc(II) and cystine bridges.
Bellia F; Pietropaolo A; Grasso G
J Mass Spectrom; 2013 Feb; 48(2):135-40. PubMed ID: 23378084
[TBL] [Abstract][Full Text] [Related]
4. Are neuropeptides FF and SF neurotransmitters in the rat?
Roumy M; Gouardères C; Mazarguil H; Zajac JM
Biochem Biophys Res Commun; 2000 Sep; 275(3):821-4. PubMed ID: 10973805
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of cryptic peptides derived from neuropeptide FF precursors: the involvement of insulin-degrading enzyme.
Grasso G; Mielczarek P; Niedziolka M; Silberring J
Int J Mol Sci; 2014 Sep; 15(9):16787-99. PubMed ID: 25247577
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
[TBL] [Abstract][Full Text] [Related]
7. AP/MALDI-MS complete characterization of the proteolytic fragments produced by the interaction of insulin degrading enzyme with bovine insulin.
Grasso G; Rizzarelli E; Spoto G
J Mass Spectrom; 2007 Dec; 42(12):1590-8. PubMed ID: 18085545
[TBL] [Abstract][Full Text] [Related]
8. Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides.
Kim YG; Lone AM; Nolte WM; Saghatelian A
Proc Natl Acad Sci U S A; 2012 May; 109(22):8523-7. PubMed ID: 22586115
[TBL] [Abstract][Full Text] [Related]
9. Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme.
Zhang Z; Liang WG; Bailey LJ; Tan YZ; Wei H; Wang A; Farcasanu M; Woods VA; McCord LA; Lee D; Shang W; Deprez-Poulain R; Deprez B; Liu DR; Koide A; Koide S; Kossiakoff AA; Li S; Carragher B; Potter CS; Tang WJ
Elife; 2018 Mar; 7():. PubMed ID: 29596046
[TBL] [Abstract][Full Text] [Related]
10. Crypteins derived from the mouse neuropeptide FF (NPFF)A precursor display NPFF-like effects in nociceptive tests in mice.
Kotlinska JH; Gibula-Bruzda E; Suder P; Wasielak M; Bray L; Raoof H; Bodzon-Kulakowska A; Silberring J
Peptides; 2012 Jul; 36(1):17-22. PubMed ID: 22580381
[TBL] [Abstract][Full Text] [Related]
11. Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid {beta} vasculotropic variants and reduced activity in cerebral amyloid angiopathy.
Morelli L; Llovera RE; Mathov I; Lue LF; Frangione B; Ghiso J; Castaño EM
J Biol Chem; 2004 Dec; 279(53):56004-13. PubMed ID: 15489232
[TBL] [Abstract][Full Text] [Related]
12. The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study.
Grasso G; Rizzarelli E; Spoto G
J Mass Spectrom; 2009 May; 44(5):735-41. PubMed ID: 19127548
[TBL] [Abstract][Full Text] [Related]
13. Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme.
McDermott JR; Gibson AM
Neurochem Res; 1997 Jan; 22(1):49-56. PubMed ID: 9021762
[TBL] [Abstract][Full Text] [Related]
14. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.
Shen Y; Joachimiak A; Rosner MR; Tang WJ
Nature; 2006 Oct; 443(7113):870-4. PubMed ID: 17051221
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
Ciaccio C; Tundo GR; Grasso G; Spoto G; Marasco D; Ruvo M; Gioia M; Rizzarelli E; Coletta M
J Mol Biol; 2009 Feb; 385(5):1556-67. PubMed ID: 19073193
[TBL] [Abstract][Full Text] [Related]
16. Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord.
Gouardères C; Tafani JA; Zajac JM
Peptides; 1998; 19(4):727-30. PubMed ID: 9622028
[TBL] [Abstract][Full Text] [Related]
17. Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme.
Çakir B; Dağliyan O; Dağyildiz E; Bariş İ; Kavakli IH; Kizilel S; Türkay M
PLoS One; 2012; 7(2):e31787. PubMed ID: 22355395
[TBL] [Abstract][Full Text] [Related]
18. Multiple allosteric sites are involved in the modulation of insulin-degrading-enzyme activity by somatostatin.
Tundo GR; Di Muzio E; Ciaccio C; Sbardella D; Di Pierro D; Polticelli F; Coletta M; Marini S
FEBS J; 2016 Oct; 283(20):3755-3770. PubMed ID: 27579517
[TBL] [Abstract][Full Text] [Related]
19. Redox regulation of insulin degradation by insulin-degrading enzyme.
Cordes CM; Bennett RG; Siford GL; Hamel FG
PLoS One; 2011 Mar; 6(3):e18138. PubMed ID: 21448434
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme.
Manolopoulou M; Guo Q; Malito E; Schilling AB; Tang WJ
J Biol Chem; 2009 May; 284(21):14177-88. PubMed ID: 19321446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
